Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Functionally relevant maculopathy and optic atrophy in spinocerebellar ataxia type 1

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
641kB

Item Type:Article
Title:Functionally relevant maculopathy and optic atrophy in spinocerebellar ataxia type 1
Creators Name:Oertel, F.C., Zeitz, O., Rönnefarth, M., Bereuter, C., Motamedi, S., Zimmermann, H.G., Kuchling, J., Grosch, A.S., Doss, S., Browne, A., Paul, F., Schmitz-Hübsch, T. and Brandt, A.U.
Abstract:BACKGROUND: Spinocerebellar ataxia type 1 (SCA‐ATXN1) is an inherited progressive ataxia disorder characterized by an adult‐onset cerebellar syndrome combined with nonataxia signs. Retinal or optic nerve affection are not systematically described. OBJECTIVES: To describe a retinal phenotype and its functional relevance in SCA‐ATXN1. METHODS: We applied optical coherence tomography (OCT) in 20 index cases with SCA‐ATXN1 and 22 healthy controls (HCs), investigating qualitative changes and quantifying the peripapillary retinal nerve fiber layer (pRNFL) thickness and combined ganglion cell and inner plexiform layer (GCIP) volume as markers of optic atrophy and outer retinal layers as markers of maculopathy. Visual function was assessed by high‐ (HC‐VA) and low‐contrast visual acuity (LC‐VA) and the Hardy‐Rand‐Rittler pseudoisochromatic test for color vision. RESULTS: Five patients (25%) showed distinct maculopathies in the ellipsoid zone (EZ). Furthermore, pRNFL (P  < 0.001) and GCIP (P = 0.002) were reduced in patients (pRNFL, 80.86 ± 9.49 μm; GCIP, 1.84 ± 0.16 mm3) compared with HCs (pRNFL, 97.02 ± 8.34 μm; GCIP, 1.98 ± 0.12 mm3). Outer macular layers were similar between groups, but reduced in patients with maculopathies. HC‐VA (P = 0.002) and LC‐VA (P  < 0.001) were reduced in patients (HC‐VA [logMAR]: 0.01 ± 010; LC‐VA [logMAR]: 0.44 ± 0.16) compared with HCs (HC‐VA [logMAR]: –0.12 ± 0.08; LC‐VA [logMAR]: 0.25 ± 0.05). Color vision was abnormal in 2 patients with maculopathies. CONCLUSIONS: A distinct maculopathy, termed EZ disruption, as well as optic atrophy add to the known nonataxia features in SCA‐ATXN1. Whereas optic atrophy may be understood as part of a widespread neurodegeneration, EZ disruption may be explained by effects of ataxin‐1 gene or protein on photoreceptors. Our findings extend the spectrum of nonataxia signs in SCA‐ATXN1 with potential relevance for diagnosis and monitoring.
Keywords:SCA-ATXN1, SCA1, Optical Coherence Tomography, Optic Atrophy, Maculopathy
Source:Movement Disorders Clinical Practice
ISSN:2330-1619
Publisher:Wiley
Volume:7
Number:5
Page Range:502-508
Date:July 2020
Official Publication:https://doi.org/10.1002/mdc3.12949
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library